Acyclic linker-containing oligonucleotides and uses thereof

Inactive Publication Date: 2005-10-20
DAMHA MASAD +4
View PDF4 Cites 43 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0071] The invention further provides a use of an oligonucleotide as defined above for preventing or decreasing translation, reverse transcription and/or replication of a target RNA in a system.
[0072] The invention further

Problems solved by technology

Current AON technologies are deficient in one or more of the criteria required for clinical utility.
However, as serum and intracellular nucleases rapidly degrade AONs with phosphodiester (PDE) linkages, AON consisting of PDE-DNA have had limited utility in such systems.
This can lead to unfavorable toxicity, especially given the high concentrations of PS-DNA needed to exert an in vivo effect.
Therefore, while the above strategies are capable of conferring increased binding to the target, such AON are unable to induce RNase H activity.
However, efforts to use PNA oligomers as antisense constructs have been hampered by poor cellular uptake and inability to activate RNase H. Very recently, PNA-[DNA]-PNA chimeras have been designed to maintain RNase H mediated cleavage via the DNA portion of the chimera (Bergman, F. et al., Tetrahedron Lett.
However, based on the presence of DNA, such a construct may be more prone to degradation in biological systems, as noted above.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Acyclic linker-containing oligonucleotides and uses thereof
  • Acyclic linker-containing oligonucleotides and uses thereof
  • Acyclic linker-containing oligonucleotides and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

Synthesis of Acyclic Precursors Suitable for their Incorporation into Oligonucleotides

Precursor to Acyclic Residue IIb

[0125] Dimethoxytrityl-O—CH2CH2CH2CH2—O—P(Ni—Pr2)OCH2CH2CN (1) was purchased from ChemGenes Corp. (Ashland, Mass.), and was used as received for the synthesis of AON-X-AON chimeras (See Example 3).

Precursor to Acyclic Residues IIc and IId

[0126] The acyclic nucleoside residues (herein referred to as 2′,3′-seconucleotides) consist of a 1-[1,5-dihydroxy-4(S)-hydroxymethyl-3-oxapent-2(R)-yl]-uracil unit which has been appropriately protected and functionalized for oligonucleotide incorporation as described below.

Step A. Synthesis of 5′-monomethoxytrityl-2′,3′-seco-β-D-ribouracil (2)

[0127]

[0128] To a 0.1 M solution of 5′-monomethoxytrityluridine (5′-MMT-rU, 5.16 g, 10 mmol; prepared as described in T. Wu, K. K. Ogilvie, R. T. Pon. 1989. “Prevention of Chain Cleavage in the Chemical Synthesis of 2′-Silylated Oligoribonucleotides.”Nucleic Acids Res., 3501-17.) in d...

example 2

Preparation of AONs Constructed from 2′-deoxy-2′-fluoro-β-D-arabinonucleotides (FANA) Flanking an Acyclic Butanediol or Secouridine Residues

1. Synthesis of FANA-X-FANA Chimeras, where X=Butanediol Linker=IIb (Y=Z=Oxygen; n=4)

[0136] The synthesis of PDE-FANA oligomers was conducted as previously described (Damha et al. J. Am. Chem. Soc. 1998, 120, 12976; Wilds, C. J. & Damha, M. J. Nucleic Acids Res. 2000, 28, 3625). Their structure was confirmed via Maldi-TOF mass spectrometry.

[0137] Synthesis of PDE-(FANA-But-FANA) chimeras were performed on a 1 micromole scale using an Expedite 8909 DNA-synthesizer. Long-chain alkylamine controlled-pore glass (LCAA-CPG) was used as the solid support. The synthesis cycle consisted of the following steps: [0138] 1)-Detritylation of nucleoside / tide bound to CPG (3% trichloroacetic acid / dichloroethane): 150 sec for MMT; 60 sec for DMT removal. [0139] 2) Coupling of 2′-F-arabinonucleoside or dimethoxytrityl-butanediol phosphoramidite monomers: 15 ...

example 3

Expression and Purification of Human RNase HII

Expression of Human RNase HII

[0159] A hrnh gene fragment from pcDNA / GS / hrnh (Invitrogen) was obtained by PCR using the primers: AGC TAT CTC GAG ATG AGC TGG CTT CTG TTC CTG GCC (XhoI) (SEQ ID NO: 30), and GGC CGC AAG CTT TCA GTC TTC CGA TTG TTT AGC TCC (HindIII) (SEQ ID NO: 31). This fragment was cloned in the XhoI / HindIII sites of the bacterial expression vector pBAD / His (Invitrogen). Recombinant human RNase HII from pBAD / His / hrnh expression plasmid was purified as follows. To overcome codon bias in E. coli, we transformed the expression vector in E. coli BL21 codonplus (Stratagene) and cultured in LB broth containing 100 μg / ml ampicillin at 37° C. until the OD600 reached 0.5-0.6. Then, the recombinant protein was induced with 0.002% arabinose for 4 h.

Purification of Human RNase HII

[0160] After induction, E. coli cells were harvested by centrifugation, washed in chilled wash buffer (100 mM phosphate, pH 8.0, 300 mM NaCl), resuspen...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Structureaaaaaaaaaa
Antisenseaaaaaaaaaa
Login to View More

Abstract

Oligonucleotides having an internal acyclic linker residue, and the preparation and uses thereof, are described. Such uses include the preparation of acyclic linker-containing antisense oligonucleotides, and their use for the prevention or depletion of function of a target nucleic acid of interest, such as RNA, in a system. Such a prevention or depletion of function includes, for example, the prevention or inhibition of the expression, reverse transcription and / or replication of the target nucleic acid, as well as the cleavage / degradation of the target nucleic acid. Accordingly, an oligonucleotide of the invention is useful for analytical and therapeutic methods and uses in which the function of a target nucleic acid is implicated, as well as a component of commercial packages corresponding to such methods and uses.

Description

FIELD OF THE INVENTION [0001] The invention relates to modified oligonucleotides and uses thereof, and particularly relates to modified oligonucleotides having one or more acyclic residues at internal positions, and uses thereof. BACKGROUND OF THE INVENTION [0002] Oligonucleotides are utilized for a variety of biotechnological applications, including primers, probes, linkers, segments to confer a site or region of interest (e.g. sites for cleavage by nucleases; coding segments), mutagenesis, or to target a particular target region or molecule to fulfill a particular purpose or function. Their ability to confer specificity by virtue of their sequence composition has resulted in their use in a number of applications in biotechnology, in particular cases with various adaptations and modifications to render them more amenable to certain applications. Such modifications may entail the attachment of various groups, or modifications to the individual nucleoside groups or portions (i.e. the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/09A61K31/7088A61K48/00A61P43/00C07H21/00C07H21/02C07H21/04C12N15/85
CPCC07H21/02C07H21/00A61P43/00
InventorDAMHA, MASADVIAZOVKINA, EKATERINAMANGOS, MARIAPARNIAK, MICHAELMIN, KYUNG-LYUM
OwnerDAMHA MASAD